HomeInsightsPE

Kopran Ltd PE Ratio

Kopran Ltd PE Ratio

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Dec 6, 2024)

stocks purchased

17.0 K

Stocks Traded

(Dec 6, 2024)

Last Updated on: Dec 08, 2024

Image

Kopran Ltd

NSE: KOPRAN

PE

19.7

Last updated on: Dec 08, 2024

Key Highlights

  • The P/E Ratio of Kopran Ltd is 19.7 as of 08 Dec 15:30 PM .
  • The P/E Ratio of Kopran Ltd changed from 7.5 on March 2019 to 24.5 on March 2024 . This represents a CAGR of 21.81% over 6 years.
  • The Latest Trading Price of Kopran Ltd is ₹ 216.3 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Kopran Ltd

No data available

Company Fundamentals for Kopran Ltd

No data available

Image

Kopran Ltd

NSE: KOPRAN

Share Price

₹ 216.3

2.30 (1.07%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Kopran Ltd

1M

1Y

3Y

5Y

Monitoring Kopran Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 2024216.3
05 Dec 2024214
04 Dec 2024215.7
03 Dec 2024214.2
02 Dec 2024210.7
29 Nov 2024214.95
28 Nov 2024220.95
27 Nov 2024221.15
26 Nov 2024215.95
25 Nov 2024220.55

SWOT Analysis Of Kopran Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kopran Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kopran Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Kopran Ltd191,043
Sun Pharmaceuticals Industries Ltd384,33,032
Divis Laboratories Ltd881,62,735
Cipla Ltd251,19,333
Torrent Pharmaceuticals Ltd641,12,773
Dr Reddys Laboratories Ltd191,04,603

Key Valuation Metric of Kopran Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Kopran Ltd

No data available

* All values are in crore

Historical Revenue of Kopran Ltd

No data available

* All values are in crore

Historical EBITDA of Kopran Ltd

No data available

* All values are in crore

Historical Net Profit of Kopran Ltd

No data available

* All values are in crore

Historical Dividend Payout of Kopran Ltd

No data available

* All values are in %

About Kopran Ltd

  • Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises.
  • The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment.
  • It manufactures semi-synthetic penicillin and is among the world's highest producers in amoxycillin.
  • Kopran also makes penicillin-G acylase, an enzyme made through fermentation.
  • It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities.

Kopran Ltd News Hub

News

Kopran schedules AGM

Kopran announced that the Annual General Meeting (AGM) of the company will be held on 11 S...

Read more

2024-08-20 00:00:00

News

Kopran consolidated net profit rises 300.72% in the June 2024 quarter

Net profit of Kopran rose 300.72% to Rs 11.10 crore in the quarter ended June 2024 as agai...

Read more

2024-08-08 00:00:00

News

Kopran to discuss results

Kopran will hold a meeting of the Board of Directors of the Company on 13 November 2024 Po...

Read more

2024-11-06 00:00:00

News

Kopran consolidated net profit declines 46.41% in the September 2024 quarter

Net profit of Kopran declined 46.41% to Rs 7.38 crore in the quarter ended September 2024 ...

Read more

2024-11-13 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Kopran Ltd

What is the current PE Ratio of Kopran Ltd?

The Current PE Ratio of Kopran Ltd is 19.74 as on 8 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 8 Dec 2024.

What was the PE Ratio of Kopran Ltd last year?

The PE Ratio of Kopran Ltd was 19.55 last year, now the PE ratio is 19.74, showing a year-on-year growth of 1.0%.

What does the PE Ratio of Kopran Ltd indicate about its stock?

The PE Ratio of Kopran Ltd is 19.74. This ratio indicates that investors are willing to pay 19.74 times the earnings per share for each share of Kopran Ltd.

What is the PE Ratio Growth of Kopran Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Kopran Ltd grew by 1.0% whereas, the EPS ratio grew by -33.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions